Insiders · Profile

Hack Andrew A. F.

Director at Atea Pharmaceuticals · Chief Financial Officer at Editas Medicine. Filing since 11 Jan 2017. CIK 0001657434

Company
Date
Role
Action
Shares
Amount
Of holding
3 Nov 2020
Director
Bought
250,000
$6.00M
4.7%
4 Feb 2019
Chief Financial Officer
Sold, plan not stated
6,895
$147.48K
100%
4 Jan 2019
Chief Financial Officer
Sold, plan not stated
7,000
$157.36K
100%
23 Nov 2018
Chief Financial Officer
Sold, plan not stated
5,284
$148.74K
100%
26 Oct 2018
Chief Financial Officer
Sold, plan not stated
6,000
$154.20K
100%
28 Sep 2018
Chief Financial Officer
Sold, plan not stated
8,000
$256.64K
100%
31 Aug 2018
Chief Financial Officer
Sold, plan not stated
10,000
$322.30K
100%
4 Jun 2018
Chief Financial Officer
Sold, plan not stated
3,000
$111.30K
100%
1 Jun 2018
Chief Financial Officer
Sold, plan not stated
7,000
$274.97K
100%
20 Mar 2018
Chief Financial Officer
Sold, plan not stated
28,000
$1.06M
100%
19 Mar 2018
Chief Financial Officer
Sold, plan not stated
6,000
$225.90K
100%
16 Mar 2018
Chief Financial Officer
Sold, plan not stated
6,000
$236.58K
100%
16 Feb 2018
Chief Financial Officer
Sold, plan not stated
6,000
$211.92K
100%
15 Feb 2018
Chief Financial Officer
Sold, plan not stated
6,000
$207.66K
100%
14 Feb 2018
Chief Financial Officer
Sold, plan not stated
6,000
$196.26K
100%
19 Dec 2017
Chief Financial Officer
Sold, plan not stated
4,649
$116.51K
100%
18 Dec 2017
Chief Financial Officer
Sold, plan not stated
5,000
$123.41K
100%
15 Dec 2017
Chief Financial Officer
Sold, plan not stated
5,000
$121.55K
100%
20 Nov 2017
Chief Financial Officer
Sold, plan not stated
5,000
$126.73K
100%
17 Nov 2017
Chief Financial Officer
Sold, plan not stated
5,000
$124.07K
100%
15 Feb 2017
Chief Financial Officer
Sold, plan not stated
3,000
$57.60K
100%
11 Jan 2017
Chief Financial Officer
Sold, plan not stated
15,000
$288.00K
100%
22 decisions on file.